Abstract: This invention relates to methods of inhibiting growth and/or proliferation of a neoplastic cell, and methods of treating neoplasms by administration of the farnesylated dibenzodiazepinone compound of Formula I via continuous intravenous infusion.
Type:
Grant
Filed:
May 16, 2006
Date of Patent:
July 27, 2010
Assignee:
Thallion Pharma Ceuticals, Inc.
Inventors:
Henriette Gourdeau, Maxime Ranger, François Berger, Bryan Simard